Dailypharm Live Search Close

Kim Sang-pyo, appointed as Moderna Korea's new GM

By Eo, Yun-Ho | translator Kang, Shin-Kook

24.08.01 05:54:02

°¡³ª´Ù¶ó 0
Will be officially appointed in August¡¦expected to make a new leap


 ¡ãKim Sang-pyo, appointed as the new General Manager of Moderna Korea.

Moderna Korea appointed Kim Sang-pyo, the former head of AstraZeneca Korea, as the new General Manager.

Moderna announced the appointment of Kim Sang-pyo as the new General Manager, effective on August 1st. Kim will head Moderna's subsidiary in South Korea, succeeding Sohn Ji-young, who led the company's establishment in the Korean market and overall business operations since 2021.

Kim stated, "South Korea is an important market for Moderna's global management strategy. I am deeply responsible for further strengthening Moderna's leadership in mRNA technology. Furthermore, I will realize Moderna's mission, which is to bring out the potential of mRNA medicines, and strive to contribute t

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)